1 1115 155 EFFICACY OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN REDUCING STRESS AND INFLAMMATION: PRELIMINARY RESULTS. OBJECTIVES: PREVIOUSLY IT WAS SHOWN THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING OXIDATIVE STRESS AND RISK OF CHRONIC DISEASES EVEN IN A SHORT DURATION. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING STRESS AND INFLAMMATION IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. DESIGN: THIS STUDY REPORTS PRELIMINARY RESULTS FROM A NONRANDOMIZED PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN. SETTING/LOCATION: THE STUDY WAS CONDUCTED AT THE INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING THESE YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: PATIENTS WITH CHRONIC INFLAMMATORY DISEASES AND OVERWEIGHT/OBESE SUBJECTS WERE INCLUDED WHILE PHYSICALLY CHALLENGED, AND THOSE ON OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THERE WAS A REDUCTION IN STRESS (PLASMA CORTISOL AND BETA-ENDORPHIN) AND INFLAMMATION (INTERLEUKIN [IL]-6 AND TUMOR NECROSIS FACTOR [TNF]-ALPHA) AT DAY 0 VERSUS DAY 10. RESULTS: EIGHTY-SIX (86) PATIENTS (44 FEMALE, 42 MALE, 40.07 +/- 13.91 YEARS) ATTENDED THIS PROGRAM. OVERALL, THE MEAN LEVEL OF CORTISOL DECREASED FROM BASELINE TO DAY 10 (149.95 +/- 46.07, 129.07 +/- 33.30 NG/ML; P=0.001) WHILE BETA-ENDORPHINS INCREASED FROM BASELINE TO DAY 10 (3.53 +/- 0.88, 4.06 +/- 0.79 NG/ML; P=0.024). ALSO, THERE WAS REDUCTION FROM BASELINE TO DAY 10 IN MEAN LEVELS OF IL-6 (2.16 +/- 0.42, 1.94 +/- 0.10 PG/ML, P=0.036) AND TNF-ALPHA (2.85 +/- 0.59, 1.95 +/- 0.32 PG/ML, P=0.002). CONCLUSIONS: THIS BRIEF YOGA-BASED LIFESTYLE INTERVENTION REDUCED THE MARKERS OF STRESS AND INFLAMMATION AS EARLY AS 10 DAYS IN PATIENTS WITH CHRONIC DISEASES; HOWEVER, COMPLETE RESULTS OF THIS STUDY WILL CONFIRM WHETHER THIS PROGRAM HAS UTILITY AS COMPLEMENTARY AND ALTERNATIVE THERAPY. 2012 2 2038 72 TELOMERASE ACTIVITY AND CELLULAR AGING MIGHT BE POSITIVELY MODIFIED BY A YOGA-BASED LIFESTYLE INTERVENTION. OBJECTIVES: RECENT STUDIES SHOWED THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING LEVELS OF OXIDATIVE STRESS AND CELLULAR AGING IN OBESE MEN. THE OBJECTIVE OF THIS CASE REPORT WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING THE LEVELS OF BIOCHEMICAL MARKERS OF CELLULAR AGEING, OXIDATIVE STRESS, AND INFLAMMATION AT BASELINE (DAY 0), AT THE END OF ACTIVE INTERVENTION (DAY 10), AND FOLLOW-UP AT DAY 90. DESIGN: SINGLE CASE REPORT FROM A PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN ASSESSING THE LEVEL OF VARIOUS MARKERS OF CELLULAR AGING. SETTING: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING MEDITATION AND YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR MANAGEMENT OF CHRONIC DISEASES. PATIENT: A 31-YEAR-OLD MAN WITH CLASS I OBESITY (BODY-MASS INDEX, 29.5 KG/M(2)) WHO PRESENTED TO THE MEDICINE OUTPATIENT DEPARTMENT AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA, WITH A HISTORY OF FATIGUE, DIFFICULTY LOSING WEIGHT, AND LACK OF MOTIVATION. HE NOTED A MARKED DECREASE IN HIS ENERGY LEVEL, PARTICULARLY IN THE AFTERNOON. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. RESULTS: FROM BASELINE (DAY 0) TO DAY 90, THE ACTIVITY OF TELOMERASE AND LEVELS OF BETA-ENDORPHINS, PLASMA CORTISOL, AND INTERLEUKIN-6 INCREASED, AND A SUSTAINED REDUCTION IN OXIDATIVE STRESS MARKERS, SUCH AS REACTIVE OXYGEN SPECIES AND 8-HYDROXY-2-DEOXY-GUANOSINE LEVELS. CONCLUSIONS: ADOPTING YOGA/MEDITATION-BASED LIFESTYLE MODIFICATION CAUSES REVERSAL OF MARKERS OF AGING, MAINLY OXIDATIVE STRESS, TELOMERASE ACTIVITY, AND OXIDATIVE DNA DAMAGE. THIS MAY NOT ONLY DELAY AGING AND PROLONG A YOUTHFUL HEALTHY LIFE BUT ALSO DELAY OR PREVENT ONSET OF SEVERAL LIFESTYLE-RELATED DISEASES, OF WHICH OXIDATIVE STRESS AND INFLAMMATION ARE THE CHIEF CAUSE. THIS REPORT SUGGESTS THIS SIMPLE LIFESTYLE INTERVENTION MAY BE THERAPEUTIC FOR OXIDATIVE DNA DAMAGE AND OXIDATIVE STRESS. 2015 3 1001 25 EFFECTS OF LAUGHTER YOGA ON HEMODIALYSIS PATIENTS' PLASMA-BETA ENDORPHIN LEVELS, PAIN LEVELS AND SLEEP QUALITY: A RANDOMIZED CONTROLLED TRIAL. THIS STUDY EVALUATES THE EFFECTS OF "LAUGHTER YOGA" ON THE PLASMA BETA-ENDORPHIN LEVELS, PAIN LEVELS AND SLEEP QUALITY OF HEMODIALYSIS PATIENTS. IT IS A RANDOMIZED CONTROLLED TRIAL. THE STUDY WAS CARRIED OUT BETWEEN JULY AND OCTOBER 2018. A TOTAL OF 68 PATIENTS RECEIVING HEMODIALYSIS TREATMENT AT TWO DIFFERENT DIALYSIS CENTERS WERE INCLUDED IN THE STUDY. THE DURATION OF THE LAUGHTER YOGA WAS 30 MIN, AND A TOTAL OF 16 SESSIONS WERE PERFORMED ON A TWICE-WEEKLY BASIS. THE DATA WERE COLLECTED BY USING A SOCIO-DEMOGRAPHIC INFORMATION FORM, THE VISUAL ANALOG SCALE AND THE PITTSBURGH SLEEP QUALITY INDEX, AND BLOOD SAMPLES WERE COLLECTED TO DETERMINE BETA-ENDORPHIN LEVELS. FOLLOWING THE LAUGHTER YOGA IMPLEMENTATION, THE PAIN LEVEL OF THE INTERVENTION GROUP PATIENTS SIGNIFICANTLY DECREASED, AND THEIR SLEEP QUALITY SIGNIFICANTLY IMPROVED. NO SIGNIFICANT CHANGE OCCURRED IN THE PATIENTS' BETA-ENDORPHIN LEVELS. LAUGHTER YOGA WAS EFFECTIVE IN REDUCING PAIN AND INCREASING SLEEP QUALITY. 2021 4 239 36 A TWO-YEAR FOLLOW-UP CASE OF CHRONIC FATIGUE SYNDROME: SUBSTANTIAL IMPROVEMENT IN PERSONALITY FOLLOWING A YOGA-BASED LIFESTYLE INTERVENTION. BACKGROUND AND OBJECTIVE: CHRONIC FATIGUE SYNDROME (CFS) IS CHARACTERIZED BY EXCESSIVE FATIGUE AFTER MINIMAL PHYSICAL OR MENTAL EXERTION, MUSCLE AND JOINT PAIN, POOR CONCENTRATION, DIZZINESS, AND SLEEP DISTURBANCES. WE REPORT HERE THE EFFECT OF A YOGA-BASED LIFESTYLE INTERVENTION IN A 30-YEAR OLD MALE PATIENT WITH A DOCUMENTED DIAGNOSIS OF CFS WITH COMPROMISED QUALITY OF LIFE (QOL) AND ALTERED PERSONALITY. METHODS: THE PATIENT INITIALLY ATTENDED A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION PROGRAM THAT CONSISTED OF YOGA-POSTURES, BREATHING EXERCISES (PRANAYAMA), MEDITATION, GROUP DISCUSSIONS, AND INDIVIDUALIZED ADVICE ON STRESS MANAGEMENT, DIET AND PHYSICAL ACTIVITY BESIDES GROUP SUPPORT. THEREAFTER, PATIENT ATTENDED 5 MORE SUCH PROGRAMS. RESULTS: THERE WAS A NOTABLE AND CONSISTENT IMPROVEMENT IN HIS CLINICAL PROFILE, POSITIVE ASPECTS OF PERSONALITY AND SUBJECTIVE WELL-BEING, AND REDUCTION IN ANXIETY FOLLOWING THIS YOGA-BASED LIFESTYLE INTERVENTION. CONCLUSION: OVERALL, THE RESULTS SUGGEST THAT LIFESTYLE INTERVENTION MAY IMPROVE CLINICAL CONDITION AND PERSONALITY IN PATIENTS WITH CFS. 2015 5 748 30 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL. 2012 6 1402 35 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179//= 23 TO <35 KG/M [2] PER ASIAN CUT-OFF VALUES] INDIVIDUALS WERE ENROLLED, AND RECEIVED DIRECTLY SUPERVISED INTERVENTION FOR 10 DAYS. THEREAFTER, THEY WERE ADVISED TO FOLLOW THIS YOGA-BASED LIFESTYLE AT HOME FOR ONE MONTH, AND WERE REASSESSED FOR STUDY VARIABLES AT DAY 30. RESULTS: THERE WAS A REDUCTION FROM BASELINE TO DAY 10 IN WEIGHT ( P <0.001), BMI ( P <0.001), WAIST/HIP-RATIO ( P <0.05), BLOOD GLUCOSE ( P <0.01), AND A SIGNIFICANT IMPROVEMENT IN LIPID PROFILE. THERE WAS A DECREASE IN MEDIAN FASTING INSULIN ( P <0.05), HOMEOSTATIC MODEL ASSESSMENT-INSULIN RESISTANCE ( P <0.01), AND IL-6 ( PP <0.05). A NON-SIGNIFICANT INCREASE IN 25-OH-VITAMIN D, AND A DECREASE IN NEOPTERIN AND VASPIN WERE OBSERVED. TWENTY SUBJECTS RETURNED FOR FOLLOW UP ASSESSMENTS. AT DAY 30, WEIGHT LOSS WAS SUSTAINED WHILE SYSTOLIC BLOOD PRESSURE ALSO SHOWED REDUCTION ( P <0.05). CHANGES IN VITAMIN D LEVELS WERE SIGNIFICANTLY AND NEGATIVELY CORRELATED WITH CHANGES IN WEIGHT, BMI AND FASTING BLOOD GLUCOSE, AND POSITIVELY WITH CHANGE IN HIGH DENSITY LIPOPROTEIN. CHANGES IN BODY WEIGHT AND BMI SIGNIFICANTLY AND POSITIVELY CORRELATED WITH INSULIN. CHANGES IN IL-6 LEVELS POSITIVELY AND SIGNIFICANTLY CORRELATED WITH CHANGE IN NEOPTERIN LEVELS. INTERPRETATION & CONCLUSIONS: THE FINDINGS SHOWED THAT IL-6, VITAMIN D, AND DIABETES RISK FACTORS WERE FAVOURABLY MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OBESITY. THIS STUDY ALSO HIGHLIGHTED THE CHALLENGES IN COMPLIANCE ASSOCIATED WITH THE FOLLOW UP OF SUBJECTS FOLLOWING AN AGGRESSIVE SUPERVISED INTERVENTION OF 10 DAYS. 2015 8 392 30 BENEFITS OF YOGA ON IL-6: FINDINGS FROM A RANDOMIZED CONTROLLED TRIAL OF YOGA FOR DEPRESSION. THE PRESENT RESEARCH SOUGHT TO EXAMINE WHETHER HATHA YOGA, IMPLEMENTED AS AN ADJUNCTIVE INTERVENTION FOR MAJOR DEPRESSION, INFLUENCES MARKERS OF INFLAMMATION. A SUBSET OF 84 PARTICIPANTS WHO WERE ENROLLED IN A RANDOMIZED CONTROLLED TRIAL (RCT) OF HATHA YOGA VS. HEALTH EDUCATION CONTROL PROVIDED BLOOD SAMPLES AT BASELINE (PRE-TREATMENT) AND AT 3-(DURING TREATMENT) AND 10-WEEK (END OF TREATMENT) FOLLOW-UP VISITS. TO BE ELIGIBLE FOR THE RCT, PARTICIPANTS MET CRITERIA FOR A CURRENT OR RECENT (PAST TWO YEARS) MAJOR DEPRESSIVE EPISODE, HAD CURRENT ELEVATED DEPRESSION SYMPTOMS, AND CURRENT ANTIDEPRESSANT MEDICATION USE. VENOUS BLOOD WAS DRAWN BETWEEN 2 AND 6 PM AND FOLLOWING AT LEAST ONE HOUR OF FASTING, AND INFLAMMATORY MARKERS (IL-6, CRP, AND TNF-ALPHA) WERE ASSAYED. EFFECTS OF PARTICIPATION IN YOGA RELATIVE TO HEALTH EDUCATION ON INFLAMMATORY MARKERS OVER TIME WERE EXAMINED WITH LATENT GROWTH ANALYSES. WE OBSERVED A SIGNIFICANT REDUCTION IN IL-6 CONCENTRATIONS IN THE YOGA TREATMENT GROUP RELATIVE TO THE HEALTH EDUCATION CONTROL GROUP AS DEMONSTRATED BY A NEGATIVE INTERACTION BETWEEN TREATMENT GROUP AND SLOPE OF IL-6. TNF-ALPHA AND CRP DID NOT EVIDENCE SIGNIFICANT INTERACTIONS OF TREATMENT GROUP BY MEAN SLOPE OR INTERCEPT. IN ADDITION TO THE BENEFITS OF HATHA YOGA AS AN ADJUNCTIVE INTERVENTION FOR INDIVIDUALS WHO HAVE SHOWN INADEQUATE RESPONSE TO ANTIDEPRESSANT MEDICATIONS, OUR FINDINGS POINT TO POSSIBLE BENEFITS OF YOGA ON IL-6 IN DEPRESSED POPULATIONS. FURTHER RESEARCH IS NEEDED TO EXPLORE THE EFFECTS OF HATHA YOGA ON IMMUNE FUNCTION OVER TIME. 2021 9 893 27 EFFECT OF YOGA-BASED PHYSICAL ACTIVITY ON PERCEIVED STRESS, ANXIETY, AND QUALITY OF LIFE IN YOUNG ADULTS. PURPOSE: THIS STUDY, CONDUCTED AT A PUBLIC UNIVERSITY IN TURKEY, SOUGHT TO DETERMINE THE EFFECTS OF YOGA-BASED PHYSICAL ACTIVITY ON PERCEIVED STRESS, ANXIETY, AND QUALITY OF LIFE IN YOUNG ADULTS. DESIGN AND METHODS: THIS STUDY WAS PLANNED AS A SEMIEXPERIMENTAL NONRANDOMIZED STUDY WITH A CONTROL GROUP. FINDINGS: YOGA-BASED PHYSICAL ACTIVITY DECREASED THE PERCEIVED STRESS AND STATE ANXIETY LEVELS, BUT HAD NO EFFECT ON TRAIT ANXIETY LEVELS AND QUALITY OF LIFE. PRACTICAL IMPLICATIONS: IT IS RECOMMENDED THAT YOGA-BASED TREATMENT CAN BE INCLUDED IN NURSING INTERVENTIONS FOR REDUCING STRESS AND ANXIETY LEVELS IN YOUNG ADULTS. 2020 10 2834 32 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 11 2644 42 YOGA FOR WOMEN WITH URGENCY URINARY INCONTINENCE: A PILOT STUDY. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE THE FEASIBILITY OF A GENTLE YOGA PROGRAM FOR WOMEN WITH URGENCY URINARY INCONTINENCE (UUI). ALSO, THESE PRELIMINARY DATA CAN EVALUATE IF YOGA IMPROVES SYMPTOM BURDEN, QUALITY OF LIFE, AND INFLAMMATORY BIOMARKERS FOR WOMEN WITH UUI. METHODS: THIS PROSPECTIVE NONRANDOMIZED SINGLE-ARM PILOT STUDY EVALUATED THE EFFECTIVENESS OF A TWICE-WEEKLY, 8-WEEK GENTLE YOGA INTERVENTION TO REDUCE UUI SYMPTOM BURDEN. CHANGES IN SYMPTOM BURDEN WERE MEASURED USING THE PELVIC FLOOR DISTRESS INVENTORY 20. SECONDARY MEASURES INCLUDED QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, SLEEP, STRESS, ANXIETY, AND INFLAMMATORY BIOMARKERS. OUTCOMES WERE EVALUATED WITH PAIRED T TESTING. RESULTS: TWELVE WOMEN COMPLETED THE YOGA INTERVENTION WITH NO ADVERSE OUTCOMES NOTED. URGENCY SYMPTOM BURDEN WAS SIGNIFICANTLY IMPROVED AFTER THE INTERVENTION (P = 0.01), AND WOMEN REPORTED AN INCREASE IN QUALITY OF LIFE (P = 0.04) AFTER THE YOGA INTERVENTION. FOLLOWING THE YOGA INTERVENTION, THE MAJORITY OF WOMEN REPORTED SYMPTOMS AS "MUCH BETTER" (N = 4 [33%]) AND "A LITTLE BETTER" (N = 5 [42%]), WITH 3 WOMEN (25%) REPORTING "NO CHANGE." WOMEN ALSO REPORTED SIGNIFICANT REDUCTION IN DEPRESSIVE SYMPTOMS (P = 0.03) AND BETTER QUALITY OF SLEEP (P = 0.03). NO SIGNIFICANT CHANGES WERE FOUND IN ANXIETY OR STRESS PERCEPTION. PLASMA LEVELS OF THE INFLAMMATORY BIOMARKER TUMOR NECROSIS FACTOR ALPHA WERE REDUCED AFTER YOGA INTERVENTION (P = 0.009); HOWEVER, NO SIGNIFICANT POSTYOGA CHANGES WERE FOUND FOR INTERLEUKIN 6 OR C-REACTIVE PROTEIN. CONCLUSIONS: THIS STUDY PROVIDES PRELIMINARY EVIDENCE THAT YOGA IS A FEASIBLE COMPLEMENTARY THERAPY THAT REDUCES INCONTINENCE SYMPTOM BURDEN, ALONG WITH IMPROVING QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, AND SLEEP QUALITY. ADDITIONALLY, YOGA MAY LOWER INFLAMMATORY BIOMARKERS ASSOCIATED WITH INCONTINENCE. 2021 12 284 77 ADIPONECTIN, INTERLEUKIN-6, AND CARDIOVASCULAR DISEASE RISK FACTORS ARE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT AND OBESE MEN. OBJECTIVE: TO INVESTIGATE THE EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD) AND MARKERS OF INFLAMMATION AND ENDOTHELIAL FUNCTION IN OVERWEIGHT AND OBESE MEN. DESIGN: NONRANDOMIZED PROSPECTIVE LIFESTYLE INTERVENTION STUDY WITH PRE-POST DESIGN. SETTING AND LOCATION: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY PROVIDING YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: OVERWEIGHT AND OBESE MEN (N=51) WERE ENROLLED IN THE STUDY. SUBJECTS WHO WERE PHYSICALLY UNABLE TO PARTICIPATE AND THOSE PARTICIPATING IN OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDING ASANAS (PHYSICAL POSTURES), PRANAYAMA (BREATHING EXERCISES), GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THE PRIMARY OUTCOME MEASURE WAS WEIGHT LOSS, AND THE SECONDARY OUTCOME MEASURES WERE CLINICAL AND LABORATORY CORRELATES OF CVD RISK, LEVELS OF INTERLEUKIN-6 (IL-6), ADIPONECTIN, AND ENDOTHELIN-1 (ET-1). RESULTS: MEN (N=51, BODY MASS INDEX [BMI] 26.26+/-2.42 KG/M(2)) WERE ENROLLED AND UNDERWENT A YOGA-BASED LIFESTYLE INTERVENTION FOR 10 DAYS. OF 51 SUBJECTS, 30 COMPLETED THE STUDY. THERE WAS A SIGNIFICANT REDUCTION IN WEIGHT FROM BASELINE TO DAY 10 (74.60+/-7.98, 72.69+/-8.37 KG, P<0.001, RESPECTIVELY), BMI (26.26+/-2.42, 25.69+/-2.47 KG/M(2), P<0.001, RESPECTIVELY), AND SYSTOLIC BP (121.73+/-11.58, 116.73+/-9.00, P=0.042, RESPECTIVELY). THERE WAS A SIGNIFICANT REDUCTION IN PLASMA IL-6 FROM BASELINE TO DAY 10 (MEDIAN 2.24 VS. 1.26 PG/ML, RESPECTIVELY, P=0.012). THERE WAS A SIGNIFICANT INCREASE IN THE PLASMA ADIPONECTIN FROM BASELINE TO DAY 10 (MEDIAN 4.95 VS. 6.26 MUG/ML, RESPECTIVELY, P=0.014). PLASMA ET-1 LEVEL REMAINED UNCHANGED. CONCLUSION: THESE FINDINGS SUGGEST THAT EVEN A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION MAY BE AN IMPORTANT MODALITY TO REDUCE THE RISK FOR CVD AS INDICATED BY WEIGHT LOSS, REDUCTION IN SYSTOLIC BLOOD PRESSURE, AN INCREASE IN ADIPONECTIN, AND DECREASE IN IL-6 IN OVERWEIGHT AND OBESE MEN. 2013 13 795 37 EFFECT OF YOGA INTERVENTION IN THE MANAGEMENT OF HYPERTENSION: A PREVENTIVE TRIAL. BACKGROUND: NONCOMMUNICABLE DISEASES ARE ON THE RISE IN INDIA. HYPERTENSION IS ONE OF THE MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASES AND ALSO LABELED AS A CHRONIC LIFESTYLE DISORDER. HENCE, NON-PHARMACOLOGICAL INTERVENTIONS LEADING TO LIFESTYLE MODIFICATIONS ARE OF UTMOST IMPORTANCE TO CONTROL AND PREVENT HYPERTENSION. THIS TRIAL AIMS TO IMPLEMENT YOGA INTERVENTION TO THE EXPERIMENTAL GROUP IN ADDITION TO MEDICINES, ADVICE ON DIET AND PHYSICAL ACTIVITY AND TO COMPARE BLOOD PRESSURE AND PERCEIVED STRESS SCORES WITH THE CONTROL GROUP. METHODS: IT WAS AN OPEN-LABEL, TWO-ARMED, NON-RANDOMIZED CONTROLLED TRIAL, CONDUCTED AT A TERTIARY CARE CENTER ON 145 PATIENTS WITH HYPERTENSION: 73 IN THE INTERVENTION GROUP AND 72 IN THE CONTROL GROUP. THE INTERVENTION GROUP RECEIVED YOGA INTERVENTION FOR A PERIOD OF 4 MONTHS ON A WEEKLY BASIS ALONG WITH ADVICE ON PHYSICAL ACTIVITY, DIET, AND ROUTINE MEDICINES. THE CONTROL GROUP DID NOT RECEIVE YOGA INTERVENTION. RESULTS: THE MEAN AGE OF THE PARTICIPANTS WAS 51.3 +/- 9.4, FEMALES (58.2%) OUTNUMBERED MALES (41.3%). FOLLOWING THE INTERVENTION, PERCEIVED STRESS SCORE AND BLOOD PRESSURE SHOWED A SIGNIFICANT REDUCTION BETWEEN TWO GROUPS (P < 0.001). ALSO, PERCEIVED STRESS AND BLOOD PRESSURE WERE FOUND TO BE REDUCED SIGNIFICANTLY WITHIN BOTH GROUPS (P < 0.001). CONCLUSIONS: YOGA PROVES TO BE AN EFFECTIVE, SAFE, AND LESS EXPENSIVE ADJUNCT THERAPY FOR HYPERTENSION MANAGEMENT. YOGA WAS ALSO FOUND TO BE EFFECTIVE IN REDUCING THE LEVEL OF STRESS. DIET MODIFICATION AND PHYSICAL ACTIVITY HAVE GOT AN IMPORTANT ROLE TO PLAY IN THE CONTROL AND PREVENTION OF HYPERTENSION. 2021 14 159 31 A RANDOMISED COMPARATIVE TRIAL OF YOGA AND RELAXATION TO REDUCE STRESS AND ANXIETY. OBJECTIVE: TO COMPARE YOGA AND RELAXATION AS TREATMENT MODALITIES AT 10 AND 16 WEEKS FROM STUDY BASELINE TO DETERMINE IF EITHER OF MODALITY REDUCES SUBJECT STRESS, ANXIETY, BLOOD PRESSURE AND IMPROVE QUALITY OF LIFE. DESIGN: A RANDOMISED COMPARATIVE TRIAL WAS UNDERTAKEN COMPARING YOGA WITH RELAXATION. PARTICIPANTS: ONE HUNDRED AND THIRTY-ONE SUBJECTS WITH MILD TO MODERATE LEVELS OF STRESS WERE RECRUITED FROM THE COMMUNITY IN SOUTH AUSTRALIA. INTERVENTIONS: TEN WEEKLY 1- H SESSIONS OF RELAXATION OR HATHA YOGA. MAIN OUTCOME MEASURES: CHANGES IN THE STATE TRAIT PERSONALITY INVENTORY SUB-SCALE ANXIETY, GENERAL HEALTH QUESTIONNAIRE AND THE SHORT FORM-36. RESULTS: FOLLOWING THE 10 WEEK INTERVENTION STRESS, ANXIETY AND QUALITY OF LIFE SCORES IMPROVED OVER TIME. YOGA WAS FOUND TO BE AS EFFECTIVE AS RELAXATION IN REDUCING STRESS, ANXIETY AND IMPROVING HEALTH STATUS ON SEVEN DOMAINS OF THE SF-36. YOGA WAS MORE EFFECTIVE THAN RELAXATION IN IMPROVING MENTAL HEALTH. AT THE END OF THE 6 WEEK FOLLOW-UP PERIOD THERE WERE NO DIFFERENCES BETWEEN GROUPS IN LEVELS OF STRESS, ANXIETY AND ON FIVE DOMAINS OF THE SF-36. VITALITY, SOCIAL FUNCTION AND MENTAL HEALTH SCORES ON THE SF-36 WERE HIGHER IN THE RELAXATION GROUP DURING THE FOLLOW-UP PERIOD. CONCLUSION: YOGA APPEARS TO PROVIDE A COMPARABLE IMPROVEMENT IN STRESS, ANXIETY AND HEALTH STATUS COMPARED TO RELAXATION. 2007 15 2353 31 UTILIZATION OF 3-MONTH YOGA PROGRAM FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES: A PILOT STUDY. VARIOUS MODES OF PHYSICAL ACTIVITY, COMBINED WITH DIETING, HAVE BEEN WIDELY RECOMMENDED TO PREVENT OR DELAY TYPE 2 DIABETES. AMONG THESE, YOGA HOLDS PROMISE FOR REDUCING RISK FACTORS FOR TYPE 2 DIABETES BY PROMOTING WEIGHT LOSS, IMPROVING GLUCOSE LEVELS AND REDUCING BLOOD PRESSURE AND LIPID LEVELS. THIS PILOT STUDY AIMED TO ASSESS THE FEASIBILITY OF IMPLEMENTING A 12-WEEK YOGA PROGRAM AMONG ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. TWENTY-THREE ADULTS (19 WHITES AND 4 NON-WHITES) WERE RANDOMLY ASSIGNED TO THE YOGA INTERVENTION GROUP OR THE EDUCATIONAL GROUP. THE YOGA GROUP PARTICIPATED IN A 3-MONTH YOGA INTERVENTION WITH SESSIONS TWICE PER WEEK AND THE EDUCATIONAL GROUP RECEIVED GENERAL HEALTH EDUCATIONAL MATERIALS EVERY 2 WEEKS. ALL PARTICIPANTS COMPLETED QUESTIONNAIRES AND HAD BLOOD TESTS AT BASELINE AND AT THE END OF 3 MONTHS. EFFECT SIZES WERE REPORTED TO SUMMARIZE THE EFFICACY OF THE INTERVENTION. ALL PARTICIPANTS ASSIGNED TO THE YOGA INTERVENTION COMPLETED THE YOGA PROGRAM WITHOUT COMPLICATION AND EXPRESSED HIGH SATISFACTION WITH THE PROGRAM (99.2%). THEIR YOGA SESSION ATTENDANCE RANGED FROM 58.3 TO 100%. COMPARED WITH THE EDUCATION GROUP, THE YOGA GROUP EXPERIENCED IMPROVEMENTS IN WEIGHT, BLOOD PRESSURE, INSULIN, TRIGLYCERIDES AND EXERCISE SELF-EFFICACY INDICATED BY SMALL TO LARGE EFFECT SIZES. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR THIS GROUP. 2011 16 2235 33 THE IMPACT OF YOGA UPON FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE QUALITY OF LIFE OF FEMALE HYPOTHYROID PATIENTS. DESIGN: THE WHO QUALITY OF LIFE SCALE(22) WAS USED TO ASSESS THE QUALITY OF LIFE OF 20 FEMALE HYPOTHYROID PATIENTS. SUBJECTS ATTENDED ONE HOUR YOGA SESSIONS DAILY FOR A PERIOD OF ONE MONTH. A PRETEST-POST-TEST RESEARCH DESIGN WAS USED FOR DATA ANALYSIS. RESULTS: PATIENTS' QUALITY OF LIFE SCORES FOLLOWING THE YOGA PROGRAM WERE GREATER THAN SCORES OBTAINED PRIOR TO UNDERTAKING YOGA (P < 0.01). PATIENTS ALSO REPORTED SIGNIFICANT IMPROVEMENT IN THEIR PERCEPTION OF THE OVERALL QUALITY OF LIFE AND OF THEIR HEALTH POST YOGA INTERVENTION. CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA IS VALUABLE IN HELPING THE HYPOTHYROID PATIENTS TO MANAGE THEIR DISEASE-RELATED SYMPTOMS. YOGA MAY BE CONSIDERED AS SUPPORTIVE OR COMPLEMENTARY THERAPY IN CONJUNCTION WITH MEDICAL THERAPY FOR THE TREATMENT OF HYPOTHYROID DISORDER. 2011 17 2613 34 YOGA FOR RISK REDUCTION OF METABOLIC SYNDROME: PATIENT-REPORTED OUTCOMES FROM A RANDOMIZED CONTROLLED PILOT STUDY. LIFESTYLE CHANGE IS RECOMMENDED AS TREATMENT FOR ADULTS AT RISK FOR METABOLIC SYNDROME (METS), ALTHOUGH ADOPTION OF NEW BEHAVIORAL PATTERNS IS LIMITED. IN ADDITION, MOST EXISTING LIFESTYLE INTERVENTIONS DO NOT ADDRESS PSYCHOLOGICAL STRESS OR QUALITY OF LIFE, BOTH OF WHICH IMPACT THE BURDEN OF METS. YOGA, A FORM OF PHYSICAL ACTIVITY THAT INCORPORATES PSYCHOLOGICAL COMPONENTS (E.G., MAINTAINING ATTENTION, RELAXATION), IS A PROMISING INTERVENTION FOR IMPROVING THE BURDEN OF METS. THIS RANDOMIZED CONTROLLED TRIAL ASSESSED THE FEASIBILITY AND PRELIMINARY EFFICACY OF A 12-WEEK YOGA PROGRAM COUPLED WITH AN EVIDENCE-BASED HEALTH EDUCATION PROGRAM (HED) COMPARED TO HED ALONE. A SECONDARY, EXPLORATORY AIM EXAMINED PERCEIVED STRESS, QUALITY OF LIFE, AND RELATED PSYCHOLOGICAL OUTCOMES (MINDFULNESS, PERCEIVED HEALTH COMPETENCE, AND MOOD). SIXTY-SEVEN ADULTS AT RISK FOR METS ENROLLED (MEAN AGE [SD]: 58 [10] YEARS; 50% MALE; 79% NON-HISPANIC WHITE). PRELIMINARY RESULTS REVEALED SIGNIFICANTLY LARGER IMPROVEMENTS IN TWO QUALITY OF LIFE DOMAINS (ROLE-PHYSICAL AND GENERAL HEALTH PERCEPTIONS) IN THE HED PLUS YOGA GROUP VERSUS HED ALONE (PS < 0.05). THIS IS THE FIRST STUDY THAT IMPLEMENTED LIFESTYLE EDUCATION ALONG WITH YOGA TO EVALUATE THE POTENTIAL UNIQUE EFFECTS OF YOGA ON PARTICIPANTS AT RISK FOR METS. A LARGER CLINICAL TRIAL IS WARRANTED TO FURTHER INVESTIGATE THESE PROMISING PATIENT-REPORTED OUTCOMES. 2016 18 1380 27 IMPACT OF LONG TERM YOGA PRACTICE ON SLEEP QUALITY AND QUALITY OF LIFE IN THE ELDERLY. BACKGROUND: SLEEP DISTURBANCES AND DECLINE IN THE PHYSICAL FUNCTIONALITY ARE COMMON CONDITIONS ASSOCIATED WITH AGING. PHARMACOLOGICAL TREATMENT OF SLEEP DISTURBANCES CAN BE ASSOCIATED WITH VARIOUS ADVERSE EFFECTS. SHORT TERM TRIALS OF YOGA ON SLEEP HAVE SHOWN BENEFICIAL EFFECTS. OBJECTIVES: TO EVALUATE THE EFFECT OF LONG-TERM YOGA EXERCISES ON SLEEP QUALITY AND QUALITY OF LIFE (QOL) IN THE ELDERLY. MATERIALS AND METHODS: THIS WAS A CROSS-SECTIONAL STUDY IN WHICH DATA WERE COLLECTED FROM ELDERLY PEOPLE AGED 60 YEARS OR MORE LIVING IN NAGPUR CITY. WE EMPLOYED TWO TYPES OF SURVEY QUESTIONNAIRES: PITTSBURGH SLEEP QUALITY INDEX (PSQI) AND QOL LEIDEN-PADUA (LEIPAD) QUESTIONNAIRE. A TOTAL OF 65 ELDERLY MEN AND WOMEN WHO SIGNED AN INFORMED CONSENT AND COMPLETED QUESTIONNAIRES WERE INCLUDED IN THE STUDY. SLEEP QUALITY SCORE PSQI AND QOL (LEIPAD QUESTIONNAIRE) SCORE OF THE STUDY GROUP WERE EVALUATED AND COMPARED WITH THE CONTROL GROUP USING MANN-WHITNEY U TEST. RESULTS: TOTAL PSQI SCORE IN YOGA GROUP WAS LOWER THAN THAT OF THE CONTROL GROUP. ALSO VARIOUS QOL SCORES OF THE YOGA GROUPS WERE HIGHER THAN THE CONTROL GROUP. CONCLUSION: ADDITION OF REGULAR YOGA EXERCISES IN THE DAILY ROUTINE OF ELDERLY PEOPLE CAN HELP TO ACHIEVE GOOD SLEEP QUALITY AS WELL AS IMPROVE THE QOL. 2013 19 2187 36 THE EFFECTS OF YOGA ON STUDENT MENTAL HEALTH: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: UNIVERSITIES AROUND THE WORLD ARE FACING AN EPIDEMIC OF MENTAL DISTRESS AMONG THEIR STUDENTS. THE PROBLEM IS TRULY A PUBLIC HEALTH ISSUE, AFFECTING MANY AND WITH SERIOUS CONSEQUENCES. THE GLOBAL BURDEN OF DISEASE-AGENDA CALLS FOR EFFECTIVE INTERVENTIONS WITH LASTING EFFECTS THAT HAVE THE POTENTIAL TO IMPROVE THE MENTAL HEALTH OF YOUNG ADULTS. IN THIS STUDY WE AIMED TO DETERMINE WHETHER YOGA, A POPULAR AND WIDELY AVAILABLE MIND-BODY PRACTICE, CAN IMPROVE STUDENT MENTAL HEALTH. METHODS: WE PERFORMED A RANDOMISED CONTROLLED TRIAL WITH 202 HEALTHY UNIVERSITY STUDENTS IN THE OSLO AREA. THE PARTICIPANTS WERE ASSIGNED TO A YOGA GROUP OR WAITLIST CONTROL GROUP IN A 1:1 RATIO BY A SIMPLE ONLINE RANDOMISATION PROGRAM. THE INTERVENTION GROUP WAS OFFERED 24 YOGA SESSIONS OVER 12 WEEKS. MEASUREMENTS WERE TAKEN AT WEEK 0 (BASELINE), WEEK 12 (POST-INTERVENTION), AND WEEK 24 (FOLLOW-UP). THE PRIMARY OUTCOME WAS PSYCHOLOGICAL DISTRESS ASSESSED BY THE HSCL-25 QUESTIONNAIRE. ANALYSIS WAS PERFORMED BASED ON THE INTENTION TO TREAT-PRINCIPLE. RESULTS: BETWEEN 24 JANUARY 2017, AND 27 AUGUST 2017, WE RANDOMLY ASSIGNED 202 STUDENTS TO A YOGA INTERVENTION GROUP (N = 100), OR WAITLIST CONTROL GROUP (N = 102). COMPARED WITH THE CONTROL GROUP, THE YOGA PARTICIPANTS DEMONSTRATED A SIGNIFICANT REDUCTION IN DISTRESS SYMPTOMS BOTH AT POST-INTERVENTION (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.15, 95% CI -0.26 TO -0.03, P = 0.0110) AND FOLLOW-UP (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.18, 95% CI -0.29 TO -0.06, P = 0.0025). SLEEP QUALITY ALSO IMPROVED AT POST-INTERVENTION AND FOLLOW-UP. NO ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: OUR FINDINGS SUGGEST THAT YOGA HAS A MODERATELY LARGE AND LASTING EFFECT, AT LEAST FOR SOME MONTHS, REDUCING SYMPTOMS OF DISTRESS AND IMPROVING SLEEP QUALITY AMONG STUDENTS. FURTHER RESEARCH SHOULD SEEK WAYS TO ENHANCE THE EFFECT, ASSESS AN EVEN LONGER FOLLOW-UP PERIOD, INCLUDE ACTIVE CONTROL GROUPS, AND CONSIDER PERFORMING SIMILAR STUDIES IN OTHER CULTURAL SETTINGS.TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT04258540. 2020 20 1328 69 HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASES FOLLOWING A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION: A NON-PHARMACOLOGICAL MODULATION. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO ASSESS THE EFFECT OF A BRIEF BUT COMPREHENSIVE YOGA-BASED LIFESTYLE INTERVENTION ON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C). METHODS: THIS PROSPECTIVE INTERVENTIONAL STUDY WAS PERFORMED AT THE INTEGRAL HEALTH CLINIC (IHC), AN OUTPATIENT FACILITY AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, A TERTIARY HEALTH CARE CENTRE, CONDUCTING YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. THE STUDY INCLUDED APPARENTLY HEALTHY NORMAL WEIGHT, OVERWEIGHT AND OBESE SUBJECTS WHO UNDERWENT A PRETESTED 10-DAY YOGA-BASED PROGRAMME INCLUDING ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), MEDITATION, GROUP DISCUSSIONS, LECTURES AND INDIVIDUALIZED ADVICE ON STRESS MANAGEMENT AND HEALTHY DIET. THE PRIMARY OUTCOME MEASURE WAS CHANGE IN SERUM HDL-C AT DAY 10 VERSUS DAY 0. RESULTS: 238 PARTICIPANTS (147 WOMEN, 91 MEN, 38.81+/-11.40 YEARS) WERE INCLUDED IN THE STUDY. THERE WAS A SIGNIFICANT INCREASE IN HDL-C LEVELS FROM BASELINE TO DAY 10 (42.93+/-5.00 VS 43.52+/-5.07 MG/DL, P = 0.043). NOTABLY, HDL-C WAS SIGNIFICANTLY IMPROVED IN THOSE FOR WHOM THE BASELINE HDL-C LEVELS WERE LOWER THAN THE RECOMMENDED VALUES. ALSO, THERE WAS A REDUCTION IN BLOOD PRESSURE, FASTING BLOOD GLUCOSE, AND IMPROVEMENT IN OTHER LIPID PROFILE VARIABLES. CONCLUSION: THIS YOGA-BASED LIFESTYLE INTERVENTION SIGNIFICANTLY INCREASED HDL-C LEVELS IN A SHORT DURATION OF 10 DAYS. THIS HAS ADDITIONAL CLINICAL RELEVANCE AS HDL-C IS SUGGESTED TO BE ONE OF THE STRONGEST STATISTICALLY INDEPENDENT PREDICTORS OF MAJOR CARDIOVASCULAR EVENTS. 2014